A Phase I, Open-Label, Multiple Ascending Dose Study of RRx-001 and Nivolumab

Clinical trial NCT02518958 · COMPLETED

Trial details

NCT number: NCT02518958
Sponsor: EpicentRx, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumor Lymphoma

Start date: 2015-07-21
Primary completion: 2016-05-17
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.